Literature DB >> 4925077

Treatment of zoster with idoxuridine in dimethyl sulphoxide. Results of two double-blind controlled trials.

B E Juel-Jensen, F O MacCallum, A M Mackenzie, M C Pike.   

Abstract

The antiviral effect of 5% idoxuridine in dimethyl sulphoxide intermittently applied and of 40% idoxuridine in dimethyl sulphoxide continuously applied for four days to the lesions in patients with zoster of recent onset was studied in two double-blind controlled trials. Most, but not all, of the patients receiving intermittent active treatment had pain for a short period only. The effect of continuous treatment was striking: pain had disappeared within nine days in all the patients and healing was accelerated. The results were statistically significant.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4925077      PMCID: PMC1820395          DOI: 10.1136/bmj.4.5738.776

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  9 in total

1.  TREATMENT OF HERPES ZOSTER WITH HIGH DOSES OF PREDNISONE.

Authors:  F A ELLIOTT
Journal:  Lancet       Date:  1964-09-19       Impact factor: 79.321

2.  DISSEMINATED HERPES ZOSTER. A REPORT OF 17 CASES.

Authors:  J G MERSELIS; D KAYE; E W HOOK
Journal:  Arch Intern Med       Date:  1964-05

3.  SPREAD OF ZOSTER VIRUS IN HUMAN EMBRYONIC LUNG CELLS AND THE INHIBITORY EFFECT OF LODODEOXYURIDINE.

Authors:  F RAPP; D VANDERSLICE
Journal:  Virology       Date:  1964-03       Impact factor: 3.616

4.  Herpetic whitlows: results of treatment with idoxuridine.

Authors:  B E Juel-Jensen
Journal:  J Am Coll Health Assoc       Date:  1970-02

5.  Clinical studies with systemic administration of antimetabolites of pyrimidine nucleosides in viral infections.

Authors:  P Calabresi
Journal:  Ann N Y Acad Sci       Date:  1965-07-30       Impact factor: 5.691

6.  The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster.

Authors:  W H Eaglstein; R Katz; J A Brown
Journal:  JAMA       Date:  1970-03-09       Impact factor: 56.272

7.  Severe generalized primary herpes treated with cytarabine.

Authors:  B E Juel-Jensen
Journal:  Br Med J       Date:  1970-04-18

8.  Herpes simplex virus skin infection in man treated with idoxuridine in dimethyl sulphoxide. Results of double-blind controlled trial.

Authors:  F O MacCallum; B E Juel-Jensen
Journal:  Br Med J       Date:  1966-10-01

9.  Ranking procedures for arbitrarily restricted observation.

Authors:  N Mantel
Journal:  Biometrics       Date:  1967-03       Impact factor: 2.571

  9 in total
  29 in total

1.  Herpes zoster in general practice.

Authors:  C A Ross; W K Brown; A Clarke; W F Caldwell; E R Gordon; J Harvey; A M McAlister; J McGlone; R T Prentice; W Thorburn; C Tobias
Journal:  J R Coll Gen Pract       Date:  1975-01

Review 2.  Herpesviruses.

Authors:  M C Timbury; E Edmond
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

3.  Shingles: a belt of roses from Hell.

Authors: 
Journal:  Br Med J       Date:  1979-01-06

4.  Cold sores-an epidemiological survey.

Authors:  P Grout; V E Barber
Journal:  J R Coll Gen Pract       Date:  1976-06

5.  Are current therapies useful for the prevention of postherpetic neuralgia? A critical analysis of the literature.

Authors:  K E Schmader; S Studenski
Journal:  J Gen Intern Med       Date:  1989 Mar-Apr       Impact factor: 5.128

6.  Oral acyclovir in acute herpes zoster.

Authors:  B E Juel-Jensen
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-11

Review 7.  Treatment of shingles and post-herpetic neuralgia.

Authors:  J V Jolleys
Journal:  BMJ       Date:  1989-06-10

8.  Antiviral treatment and postherpetic neuralgia.

Authors:  P Klenerman; T E Peto; G A Luzzi; B E Juel-Jensen
Journal:  BMJ       Date:  1989-03-25

Review 9.  Antiviral therapy of acute herpes zoster in older patients.

Authors:  K Herne; R Cirelli; P Lee; S K Tyring
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

10.  Double blind trial in the treatment of herpes simplex and herpes zoster with adenine arabinoside and idoxuridine.

Authors:  A Theodoridis; C Sivenas; A Vagena; J Capetanakis
Journal:  Arch Dermatol Res       Date:  1978-07-28       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.